insights_auto
Outlook: Optimistická perspektíva: 20.0 %·Pesimistická perspektíva: 30.0 %
Prejsť na analýzuchevron_right
M1RN34:BVMF
Moderna Inc Bdr
56,00 BRL
0,00%
(0,00) 1 d.
9. 10., 17:06:00 GMT-3 · BRL
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre M1RN34…
Otvoriť
49,70 BRL
Vysoká
56,00 BRL
Nízka
49,30 BRL
Trh. kap.
89,83 mld.
Priem. obj.
105,76 tis.
Objem
237,49 tis.
Max. za 52 týž.
56,00 BRL
Min. za 52 týž.
6,02 BRL
Akcie v obehu
399,24 mil.
Počet zamestnancov
5 tis.
Otvoriť
49,70 BRL
Vysoká
56,00 BRL
Nízka
49,30 BRL
Trh. kap.
89,83 mld.
Priem. obj.
105,76 tis.
Objem
237,49 tis.
Max. za 52 týž.
56,00 BRL
Min. za 52 týž.
6,02 BRL
Akcie v obehu
399,24 mil.
Počet zamestnancov
5 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
MarketBeat
·
pred 12 hodinami
11,652 Shares of Moderna, Inc. $MRNA Acquired by Gallagher Capital Advisors LLC
NAI500
·
pred 13 hodinami
Moderna Stock Soars as New Cancer Research Initiative Ignites Market Enthusiasm
The Globe and Mail
·
pred 1 dňom
This Stock Is Up More than 560% This Year, but It Could Drop by 38%, According to Wall Street
Yahoo Finance
·
pred 1 dňom
Moderna stock hits 4-year high on planned national cancer vaccine effort
Profil
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Informácie o subjekte Moderna Inc Bdr
Generálny riaditeľStéphane Bancel
Zamestnanci4,7 tis.
Dátum založeniasep 2010
Hlavné sídlo-
Odvetvie-